Toll-like receptor 4 genetic variants and prognosis of breast cancer

Tissue Antigens

Volumn 81, Issue 4, 2013, Pages 221-226

  Yang, C X ^a   Li, C Y ^b   Feng, W ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Polymorphism; Toll like receptor 4

Indexed keywords

TOLL LIKE RECEPTOR 4;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME;

ADULT; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SURVIVAL ANALYSIS; TOLL-LIKE RECEPTOR 4;

EID: 84875539687     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12096     Document Type: Article

References (23)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012: 62: 10-29.
2. Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M. Genetic susceptibility to breast cancer. Mol Oncol 2010: 4: 174-91.
3. Yu JC, Ding SL, Chang CH et al. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. Carcinogenesis 2009: 30: 1562-70.
4. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor 4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999: 274: 10689-92.
5. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006: 116: 3015-25.
6. Schreibelt G, Tel J, Sliepen KH et al. Tolllike receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy. Cancer Immunol Immunother 2010: 59: 1573-82.
7. Liu H, Komai-Koma M, Xu D, Liew FY. Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells. Proc Natl Acad Sci USA 2006: 103: 7048-53.
8. Sutmuller RP, den Brok MH, Kramer M et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006: 116: 485-94.
9. Kabelitz D. Expression and function of Toll-like receptors in T lymphocytes. Curr Opin Immunol 2007: 19: 39-45.
10. Huang B, Zhao J, Li H et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005: 65: 5009-14.
11. Kelly MG, Alvero AB, Chen R et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 2006: 66: 3859-68.
12. Arbour NC, Lorenz E, Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000: 25: 187-91.
13. de Oliveira JG, Silva AE. Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population. World J Gastroenterol 2000: 18: 1235-42.
14. Akil I, Ozkinay F, Onay H, Canda E, Gumuser G, Kavukcu S. Assessment of Toll-like receptor-4 gene polymorphism on pyelonephritis and renal scar. Int J Immunogenet 2012: 39: 303-7.
15. Agúndez JA, García-Martín E, Devesa MJ et al. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma. Oncology 2012: 82: 35-40.
16. Creely SJ, McTernan PG, Kusminski CM et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007: 292: E740-7.
17. Manolakis AC, Kapsoritakis AN, Tiaka EK et al. TLR4 gene polymorphisms: evidence for protection against type 2 diabetes but not for diabetes-associated ischaemic heart disease. Eur J Endocrinol 2011: 165: 261-7.
18. González-Reyes S, Marín L, González L et al. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC Cancer 2010: 10: 665. DOI: 10.1186/1471-2407-10-665.
19. Sato K, Yoshimura A, Kaneko T et al. A single nucleotide polymorphism in 3'-untranslated region contributes to the regulation of Toll-like receptor 4 translation. J Biol Chem 2012: 287: 25163-72.
20. Hishida A, Matsuo K, Goto Y et al. Toll-like receptor 4 +3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese. Helicobacter 2009: 14: 47-53.
21. Zhou L, Wei B, Xing C et al. Polymorphism in 3'-untranslated region of toll-like receptor 4 gene is associated with protection from hepatitis B virus recurrence after liver transplantation. Transpl Infect Dis 2011: 13: 250-8.
22. Cohen SM, Shirai T, Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl 2000: 34: 105-15.
23. Chen K, Wang YT, Gu W et al. Functional significance of the Toll-like receptor 4 promoter gene polymorphisms in the Chinese Han population. Crit Care Med 2010: 38: 1292-9.